Les Henderson

Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer

Daniel V.T. Catenacci, Melissa R. Junttila, Theodore Karrison et al. · Journal of Clinical Oncology · 2015 · 524 citations

Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition

Gabrielle S. Wong, Jin Zhou, Jie Bin Liu et al. · Nature Medicine · 2018 · 268 citations · Full text

Tumor Biology, Oncology, Esophageal Cancer +9

Durable Complete Response of Metastatic Gastric Cancer with Anti-Met Therapy Followed by Resistance at Recurrence

Daniel V.T. Catenacci, Les Henderson, Shu‐Yuan Xiao et al. · Cancer Discovery · 2011 · 112 citations

RON<i>(MST1R)</i>is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma

Daniel V.T. Catenacci, Gustavo M. Cervantes, Soheil Yala et al. · Cancer Biology & Therapy · 2011 · 103 citations

Engineering, Esophageal Cancer, Gastroenterology +18

Copy Number Variation of CCL3-like Genes Affects Rate of Progression to Simian-AIDS in Rhesus Macaques (Macaca mulatta)

Jeremiah D. Degenhardt, Paola de Candia, Adrien E. Chabot et al. · PLoS Genetics · 2009 · 68 citations · Full text

Genetics, Immunology, Molecular Genetics +16